id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-P-5687-0003,FDA,FDA-2023-P-5687,"Interim Response Letter from FDA CDER to Bionpharma, Inc.",Other,Response(s),2024-06-20T04:00:00Z,2024,6,2024-06-20T04:00:00Z,,2024-06-20T13:18:57Z,,0,0,09000064865c0a3b